Abstract
The diversity, complexity and volume, as well as privacy and regulatory considerations, necessitate a collaborative and federated approach to life-science data. For scientists to find and share data across Europe and world-wide, ELIXIR needs to continuously develop and connect its services. The international ecosystem provided by ELIXIR – with 220 institutes in 23 Nodes, connecting hundreds of bioinformatics services – is globally unique and a competitive advantage for European research. Through our national Nodes ELIXIR has the geographical spread, service portfolio and expertise to fulfil our ambition that every European project uses FAIR data based on common standards, tools and services. The initial operational phase of ELIXIR, supported by the H2020 ELIXIR-EXCELERATE project, focussed on the coordination and delivery of bioinformatics services from national Nodes. This lay the foundation for a coordinated European infrastructure. ELIXIR-CONVERGE will build on these achievements to deliver another critical component: the provisioning, across Europe, of distributed local support for data management based on a toolkit for researchers that enables lifecycle management for their research data according to international standards. ELIXIR-CONVERGE will develop the national operations of such a distributed research infrastructure to drive good data management, reproducibility and reuse in a heterogeneous funding landscape. Over 36 months and with partners from our 23 Nodes, ELIXIR-CONVERGE takes the next step to realise a European data federation where interconnected national operations, strategically managed via national research infrastructure roadmaps, allow users to extract knowledge from life science’s large, diverse and distributed datasets. By connecting ELIXIR Nodes to provide FAIR data management as a service, ELIXIR-CONVERGE will build national capacity and create a blueprint for operating sustainable Nodes in distributed research infrastructures.
Project details
Unibo Team Leader: Pier Luigi Martelli
Unibo involved Department/s:
Dipartimento di Farmacia e Biotecnologie
Coordinator:
EMBL - European Molecular Biology Laboratory - Hamburg(Germany)
Other Participants:
Weizmann Institute of Science
(Israel)
The University Of Manchester
(United Kingdom)
University Of Cambridge
(United Kingdom)
Vib Nucleomics Core
(Belgium)
Danmarks Tekniske Universitet
(Denmark)
Inra Cnrgv
(France)
C.N.R.S. Plateforme Macle
(France)
USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.-Institute of Organic Chemistry and Biochemistry
(Czech Republic)
CSC-TIETEEN TIETOTEKNIIKAN KESKUS OY-CSC - IT Center for Science
(Finland)
Termeszettudomanyi Kutatokozpont
(Hungary)
University College Dublin (Ucd)
(Ireland)
Universite Du Luxembourg
(Luxembourg)
Stichting Dtl Projects
(Netherlands)
Inesc Id - Instituto De Engenhariade Sistemas E Computadores, Investigacao E Desenvolvimento Em Lisboa
(Portugal)
Hits Ggmbh
(Germany)
Biomedical Sciences Research Center Alexander Fleming
(Greece)
Centre For Research And Technology Hellas
(Greece)
Universitetet i Bergen - University of Bergen
(Norway)
UPPSALA UNIVERSITET - Uppsala Genome Center
(Sweden)
Sib Institut Suisse De Bioinformatique
(Switzerland)
University Of Cyprus
(Cyprus)
Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Plirofoforias, Ton Epikolnonion Kai Tis Gnosis-Imis Athena Research And Innovation
(Greece)
Consiglio Nazionale Delle Ricerche
(Italy)
Fundacao Calouste Gulbenkian - Biblioteca De Arte
(Portugal)
Barcelona Supercomputing Center - Centro Nacional De Supercomputacion
(Spain)
Univerza V Ljubljani - University Of Ljubljana
(Slovenia)
The Cyprus Foundation For Muscular Dystrophy Research
(Cyprus)
University Of Tartu
(Estonia)
Third parties:
ALMA MATER STUDIORUM - Università di Bologna
(Italy)
Total Eu Contribution: Euro (EUR) 7.800.000,00
Project Duration in months: 36
Start Date:
01/02/2020
End Date:
31/01/2023
Cordis webpage
Project website
This project contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871075